HMD
HERAMED FPO [HMD]
Healthcare · ASX Small Cap
$0.0420 +0.0%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical58
Catalyst55
Sentiment50
Fundamental28
Momentum79
Risk Gate37
Get alerts when HMD's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is losing steam
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Drifting lower — down 6.7% over the last 5 days
- Beating the Small Ords index — relative strength of 1.23, so it's outpacing the pack
- Trading above the 200-day average — the long-term trend is on your side
- Critical cash runway (1.5 quarters)
- Very high P/S ratio (108.6x)
- Small-cap ($20-100M)
- Capital raise activity (1 events)
- Sentiment is mixed — no strong consensus either way
- Strong long-term momentum — up 192% over the past year (excluding last month)
- Excellent risk-adjusted returns — Sharpe of 1.7 means strong gains without wild swings
- The bigger volume days are the up days — volume-weighted momentum is positive (1.09%/day)
- Altman Z-Score distress zone (1.59 < 1.81, low-confidence approx)
- Low-priced stock risk ($0.042)
- RBA hiking (-3pts)
Risk Signals
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about HMD
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Change of Director's Interest Notice - AG
NONE Cleansing Notice
NONE Application for quotation of securities - HMD
LOW Annual Report to shareholders
Announcement tone +5pts
Recent ASX Announcements
| 2026-03-16 | Change of Director's Interest Notice - AG |
| 2026-03-11 | Cleansing Notice |
| 2026-03-11 | Application for quotation of securities - HMD |
| 2026-02-26 | Appendix 4G and Corporate Governance Statement |
| 2026-02-26 | Annual Report to shareholders |
Key Metrics
$46.9M
Market Cap
1.2M
Avg Volume
1.4x
Vol Ratio
$0.01 — $0.05
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-223.2%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 69% |
| L | Leader vs Laggard | pass | RS: 4 |
| I | Institutional Sponsorship | weak | Inst: 4% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #89 of 117 · Sector avg: 46
View all Healthcare signals →Track HMD and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required